These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3258292)

  • 1. Dose planning with SPECT.
    Ljungberg M; Strand SE
    Int J Cancer Suppl; 1988; 2():67-70. PubMed ID: 3258292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects.
    Munley MT; Marks LB; Scarfone C; Sibley GS; Patz EF; Turkington TG; Jaszczak RJ; Gilland DR; Anscher MS; Coleman RE
    Lung Cancer; 1999 Feb; 23(2):105-14. PubMed ID: 10217614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative SPECT imaging for diagnosis and dosimetry in radionuclide therapy.
    Logan KW
    Int J Rad Appl Instrum B; 1987; 14(3):205-9. PubMed ID: 3499423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging technologies for radionuclide dosimetry.
    Ott RJ
    Phys Med Biol; 1996 Oct; 41(10):1885-94. PubMed ID: 8912368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensity modulated radiotherapy of non-small-cell lung cancer incorporating SPECT ventilation imaging.
    Munawar I; Yaremko BP; Craig J; Oliver M; Gaede S; Rodrigues G; Yu E; Reid RH; Leung E; Urbain JL; Chen J; Wong E
    Med Phys; 2010 Apr; 37(4):1863-72. PubMed ID: 20443508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation in 131I-radioimmunotherapy using SPECT.
    Riggs SJ; Green AJ; Begent RH; Bagshawe KD
    Int J Cancer Suppl; 1988; 2():95-8. PubMed ID: 3258293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accurate dosimetry in 131I radionuclide therapy using patient-specific, 3-dimensional methods for SPECT reconstruction and absorbed dose calculation.
    Dewaraja YK; Wilderman SJ; Ljungberg M; Koral KF; Zasadny K; Kaminiski MS
    J Nucl Med; 2005 May; 46(5):840-9. PubMed ID: 15872359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation and evaluation of patient-specific three-dimensional internal dosimetry.
    Kolbert KS; Sgouros G; Scott AM; Bronstein JE; Malane RA; Zhang J; Kalaigian H; McNamara S; Schwartz L; Larson SM
    J Nucl Med; 1997 Feb; 38(2):301-8. PubMed ID: 9025759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single photon emission computed tomography and positron emission tomography in cancer imaging.
    Coleman RE
    Cancer; 1991 Feb; 67(4 Suppl):1261-70. PubMed ID: 1991287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A technique using 99mTc-mebrofenin SPECT for radiotherapy treatment planning for liver cancers or metastases.
    Shen S; Jacob R; Bender LW; Duan J; Spencer SA
    Med Dosim; 2014; 39(1):7-11. PubMed ID: 24094571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 3-dimensional absorbed dose calculation method based on quantitative SPECT for radionuclide therapy: evaluation for (131)I using monte carlo simulation.
    Ljungberg M; Sjögreen K; Liu X; Frey E; Dewaraja Y; Strand SE
    J Nucl Med; 2002 Aug; 43(8):1101-9. PubMed ID: 12163637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MIRD pamphlet No. 17: the dosimetry of nonuniform activity distributions--radionuclide S values at the voxel level. Medical Internal Radiation Dose Committee.
    Bolch WE; Bouchet LG; Robertson JS; Wessels BW; Siegel JA; Howell RW; Erdi AK; Aydogan B; Costes S; Watson EE; Brill AB; Charkes ND; Fisher DR; Hays MT; Thomas SR
    J Nucl Med; 1999 Jan; 40(1):11S-36S. PubMed ID: 9935083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional dose-volume histograms for functionally heterogeneous normal organs.
    Lu Y; Spelbring DR; Chen GT
    Phys Med Biol; 1997 Feb; 42(2):345-56. PubMed ID: 9044417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunotherapy dosimetry--a review.
    Strand SE; Jönsson BA; Ljungberg M; Tennvall J
    Acta Oncol; 1993; 32(7-8):807-17. PubMed ID: 8305230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional Radiation Dose-Response Modeling of Functional Liver in Hepatocellular Carcinoma Patients With Longitudinal Sulfur Colloid SPECT/CT: A Proof of Concept.
    Price RG; Apisarnthanarax S; Schaub SK; Nyflot MJ; Chapman TR; Matesan M; Vesselle HJ; Bowen SR
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1349-1356. PubMed ID: 29932945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential hepatic avoidance radiation therapy: Proof of concept in hepatocellular carcinoma patients.
    Bowen SR; Saini J; Chapman TR; Miyaoka RS; Kinahan PE; Sandison GA; Wong T; Vesselle HJ; Nyflot MJ; Apisarnthanarax S
    Radiother Oncol; 2015 May; 115(2):203-10. PubMed ID: 25934165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D absorbed dose calculations based on SPECT: evaluation for 111-In/90-Y therapy using Monte Carlo simulations.
    Ljungberg M; Frey E; Sjögreen K; Liu X; Dewaraja Y; Strand SE
    Cancer Biother Radiopharm; 2003 Feb; 18(1):99-107. PubMed ID: 12667313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A potential to reduce pulmonary toxicity: the use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-small cell lung cancer.
    Lavrenkov K; Christian JA; Partridge M; Niotsikou E; Cook G; Parker M; Bedford JL; Brada M
    Radiother Oncol; 2007 May; 83(2):156-62. PubMed ID: 17493699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Monte-Carlo program converting activity distributions to absorbed dose distributions in a radionuclide treatment planning system.
    Tagesson M; Ljungberg M; Strand SE
    Acta Oncol; 1996; 35(3):367-72. PubMed ID: 8679268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative SPECT in radiation dosimetry.
    Zanzonico PB; Bigler RE; Sgouros G; Strauss A
    Semin Nucl Med; 1989 Jan; 19(1):47-61. PubMed ID: 2652307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.